CAS 1933507-63-1
:Formule :C36H58N2O5S
InChI :InChI=1S/C36H58N2O5S/c1-8-26-30-21-24(39)15-18-36(30,7)29-16-19-35(6)27(13-14-28(35)31(29)32(26)40)22(2)17-20-37-33(41)38-44(42,43)25-11-9-23(10-12-25)34(3,4)5/h9-12,22,24,26-32,39-40H,8,13-21H2,1-7H3,(H2,37,38,41)/t22-,24-,26-,27-,28+,29+,30+,31+,32-,35-,36-/m1/s1
Code InChI :SJKLCUGQVVYDCX-HRNVLBFRSA-N
SMILES :CC[C@@H]1[C@@H]2C[C@@H](CC[C@@]2([C@H]3CC[C@]4([C@H]([C@@H]3[C@@H]1O)CC[C@@H]4[C@H](C)CCNC(=O)NS(=O)(=O)C5=CC=C(C=C5)C(C)(C)C)C)C)O
Filtrer par
Pourcentage de pureté
0
100
|
0
|
50
|
90
|
95
|
100
4 produits trouvés.
- Tri par prix ascendant
- Tri par prix descendant
- Puretés inférieures
- Puretés supérieures
- Livraison estimée la plus rapide
4-(1,1-Dimethylethyl)-N-[[[(3α,5β,6α,7α)-6-ethyl-3,7-dihydroxy-24-norcholan-23-yl]amino]carbonyl]benzenesulfonamide
CAS :4-(1,1-Dimethylethyl)-N-[[[(3α,5β,6α,7α)-6-ethyl-3,7-dihydroxy-24-norcholan-23-yl]amino]carbonyl]benzenesulfonamideFormule :C36H58N2O5SDegré de pureté :96%Masse moléculaire :630.924-(1,1-Dimethylethyl)-N-[[[(3α,5β,6α,7α)-6-ethyl-3,7-dihydroxy-24-norcholan-23-yl]amino]carbonyl]benzenesulfonamide
CAS :Formule :C36H58N2O5SDegré de pureté :96%Couleur et forme :SolidMasse moléculaire :630.9211EDP-305
CAS :EDP-305 is a potent and selective inhibitor of kinases that are involved in tumor growth and progression. This medicinal compound has shown promising results as an anticancer agent in preclinical studies. EDP-305 has been found to induce apoptosis, or programmed cell death, in cancer cells by inhibiting the activity of specific kinases. The compound has also been shown to inhibit the proliferation of cancer cells and reduce tumor growth in animal models. EDP-305 is an analog of a Chinese herbal medicine that has been used traditionally for its anticancer properties. This protein inhibitor is excreted through urine and may have potential as a therapeutic agent for various types of cancer.Formule :C36H58N2O5SDegré de pureté :Min. 95%Masse moléculaire :630.9 g/molEDP-305
CAS :EDP-305 is an oral non-bile acid FXR agonist for NAFLD and fibrosis research.Formule :C36H58N2O5SDegré de pureté :97.17%Couleur et forme :SolidMasse moléculaire :630.921
